drugset / Trial / NCT02947373

Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors

NCT02947373

Phase 1 Completed 10 enrolled University of California, San Francisco
NaSingle-groupOpen-labelOther

Summary

This is a single arm pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC). The pilot study will look at the safety and toxicity of acquiring hyperpolarized carbon-13 imaging in children with brain tumors.

Timeline

Start
2017-01-25
Primary completion
2020-04-30
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyperpolarized Pyruvate Diagnostic / imaging agent

Indications